1. Home
  2. ZS vs ILMN Comparison

ZS vs ILMN Comparison

Compare ZS & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZS
  • ILMN
  • Stock Information
  • Founded
  • ZS 2007
  • ILMN 1998
  • Country
  • ZS United States
  • ILMN United States
  • Employees
  • ZS N/A
  • ILMN N/A
  • Industry
  • ZS EDP Services
  • ILMN Medical Specialities
  • Sector
  • ZS Technology
  • ILMN Health Care
  • Exchange
  • ZS Nasdaq
  • ILMN Nasdaq
  • Market Cap
  • ZS 28.4B
  • ILMN 23.1B
  • IPO Year
  • ZS 2018
  • ILMN 2000
  • Fundamental
  • Price
  • ZS $209.07
  • ILMN $133.49
  • Analyst Decision
  • ZS Buy
  • ILMN Buy
  • Analyst Count
  • ZS 36
  • ILMN 20
  • Target Price
  • ZS $215.91
  • ILMN $160.68
  • AVG Volume (30 Days)
  • ZS 1.3M
  • ILMN 2.2M
  • Earning Date
  • ZS 12-02-2024
  • ILMN 11-04-2024
  • Dividend Yield
  • ZS N/A
  • ILMN N/A
  • EPS Growth
  • ZS N/A
  • ILMN N/A
  • EPS
  • ZS N/A
  • ILMN N/A
  • Revenue
  • ZS $2,167,771,000.00
  • ILMN $4,390,000,000.00
  • Revenue This Year
  • ZS $24.18
  • ILMN N/A
  • Revenue Next Year
  • ZS $20.80
  • ILMN $4.00
  • P/E Ratio
  • ZS N/A
  • ILMN N/A
  • Revenue Growth
  • ZS 34.07
  • ILMN N/A
  • 52 Week Low
  • ZS $153.45
  • ILMN $90.96
  • 52 Week High
  • ZS $259.61
  • ILMN $156.66
  • Technical
  • Relative Strength Index (RSI)
  • ZS 62.68
  • ILMN 36.20
  • Support Level
  • ZS $198.68
  • ILMN $129.15
  • Resistance Level
  • ZS $217.84
  • ILMN $156.66
  • Average True Range (ATR)
  • ZS 5.95
  • ILMN 5.24
  • MACD
  • ZS 0.42
  • ILMN -2.64
  • Stochastic Oscillator
  • ZS 69.24
  • ILMN 6.91

About ZS Zscaler Inc.

Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: